A condition may be “rare,” but no person should feel invisible.
At JY MedTech, we recognize the resilience of the rare disease community and the importance of continued collaboration across science and healthcare.
Today, we stand with patients, families, advocates, and researchers working to increase awareness and accelerate progress.
JYMed Peptides Begins Planning for New Production Lines to Expand Peptide API Manufacturing Capacity
Against the backdrop of sustained growth in the global peptide drug industry, and steadily increasing global client...





0 Comments